Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mathilde Lorscheider"'
Autor:
Rosana Simón-Vázquez, Nicolas Tsapis, Mathilde Lorscheider, Ainhoa Rodríguez, Patricia Calleja, Ludivine Mousnier, Encarnación de Miguel Villegas, África González-Fernández, Elias Fattal
Publikováno v:
Drug Delivery and Translational Research
Graphical abstract Targeted delivery of dexamethasone to inflamed tissues using nanoparticles is much-needed to improve its efficacy while reducing side effects. To drastically improve dexamethasone loading and prevent burst release once injected int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efb484b643e658a5a64a79610826aad6
http://europepmc.org/articles/PMC8734546
http://europepmc.org/articles/PMC8734546
Autor:
Kadi-Liis Veiman, Mathilde Lorscheider, Christophe Chassaing, Joël Richard, Alice Gaudin, Jessica Nakhle
Publikováno v:
Therapeutic Delivery. 12:55-76
Global cancer prevalence has continuously increased in the last decades despite substantial progress achieved for patient care. Cancer is no longer recognized as a singular disease but as a plurality of different ones, leading to the important choice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7b06f01b7f7ec1e45b88305663930e
https://doi.org/10.4155/tde-2020-0079
https://doi.org/10.4155/tde-2020-0079
Publikováno v:
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Wiley, In press, ⟨10.1002/wnan.1630⟩
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, Wiley, In press, ⟨10.1002/wnan.1630⟩
Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects 0.5-1% of the world population. Current treatments include on one hand non-steroidal anti-inflammatory drugs and glucocorticoids (GCs) for treating pain and on the other hand dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0036dc1955cd10e246844af711333f6
https://pubmed.ncbi.nlm.nih.gov/32202079
https://pubmed.ncbi.nlm.nih.gov/32202079
Autor:
Rosana Simón-Vázquez, Sonia Abreu, Romain Canioni, Nicolas Guiblin, Franceline Reynaud, Nicolas Tsapis, Elias Fattal, Mathilde Lorscheider, Pierre Chaminade, Nour-Eddine Ghermani
Publikováno v:
Molecular Pharmaceutics
Molecular Pharmaceutics, American Chemical Society, 2019, 16 (7), pp.2999-3010. ⟨10.1021/acs.molpharmaceut.9b00237⟩
Molecular Pharmaceutics, American Chemical Society, 2019, 16 (7), pp.2999-3010. ⟨10.1021/acs.molpharmaceut.9b00237⟩
International audience; ⊥ Lip(Sys) 2 EA7357 Lipides, Systemes analytiques et biologiques, Univ. Paris-Sud, Univ. Paris-Saclay, ABSTRACT: The encapsulation of glucocorticoids, such as dexamethasone, in nanoparticles (NPs) faces two main issues: a lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f778d22b50643085027ee18f303b94c2
https://pubmed.ncbi.nlm.nih.gov/31117740
https://pubmed.ncbi.nlm.nih.gov/31117740
Autor:
Elias Fattal, Nicolas Tsapis, Marion Espéli, Pierre Chaminade, Françoise Gaudin, Mujeeb ur-Rehman, Sonia Abreu, Simona Mura, Mathilde Lorscheider, Ivana Stolfa
Publikováno v:
Journal of Controlled Release
Journal of Controlled Release, Elsevier, 2019, 296, pp.179-189. ⟨10.1016/j.jconrel.2019.01.015⟩
Journal of Controlled Release, 2019, 296, pp.179-189. ⟨10.1016/j.jconrel.2019.01.015⟩
Journal of Controlled Release, Elsevier, 2019, 296, pp.179-189. ⟨10.1016/j.jconrel.2019.01.015⟩
Journal of Controlled Release, 2019, 296, pp.179-189. ⟨10.1016/j.jconrel.2019.01.015⟩
International audience; Rheumatoid arthritis (RA) is a prevalent autoimmune disease characterized by joint inflammation, bone and cartilage erosion. The use of glucocorticoids in the treatment of RA is hampered by significant side effects induced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e094e533725262eb7b0889b6e974c81
https://hal.archives-ouvertes.fr/hal-02323608
https://hal.archives-ouvertes.fr/hal-02323608
